Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
about
A prospective study of lenalidomide monotherapy for relapse after Allo-SCT for multiple myelomaGraft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.A long road of T-cells to cure cancer: from adoptive immunotherapy with unspecific cellular products to donor lymphocyte infusions and transfer of engineered tumor-specific T-cells.Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effectsInfusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in OncologyIn pursuit of the allo-immune response in multiple myeloma: where do we go from here?Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia.Drug-mediated and cellular immunotherapy in multiple myeloma.Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies.Induction of multiple myeloma-reactive T cells during post-transplantation immunotherapy with donor lymphocytes and recipient DCs.Combination of intra-bone marrow-bone marrow transplantation and subcutaneous donor splenocyte injection diminishes risk of graft-versus-host disease and enhances survival rate.Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma.Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.CAR T cell therapy for multiple myeloma: where are we now and where are we headed?
P2860
Q33412636-CC2A2A51-8C21-40E3-9F62-AE23C0A0931BQ33770125-CE89F665-3178-46E4-8A44-BF2ABC62E36BQ36062047-ABA3F932-821A-4DA4-9A59-3A77B10536ADQ36380188-E11C347A-2FCA-4FBA-AC30-76E61C81574AQ36700598-9D16840B-54DD-4D6E-8F88-557C2EB9EE0FQ36963203-BB20164D-DA12-4AE9-8027-8A9FF7A6C077Q37349835-FE83CC21-4A4F-4859-8A90-038AEE34BAA0Q37412327-135CE2A9-6C45-4BFC-AE0B-F52285AD16B2Q37773257-AA9E3246-B956-4689-84BA-72499356934CQ37810098-12A98C99-48E5-404E-AFE4-14DCF104889AQ39412098-7D3650C0-4750-4143-97B2-AFA75CE5C530Q41900749-24AFC032-C1FF-4D75-BF44-F7482D690FB2Q43067059-1B222BF5-EE41-4890-B5AF-65733F023DF3Q43640246-5DE2641F-19D3-4357-8947-A207A82B681EQ45756098-AD35C3BF-8AC6-47A4-9AF4-18EB172D0860Q47565827-7D1B2545-2E0B-427E-BB91-29D9646DF080
P2860
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
@ast
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
@en
type
label
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
@ast
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
@en
prefLabel
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
@ast
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
@en
P2093
P2860
P356
P1476
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704670
P407
P577
2004-12-01T00:00:00Z
P5875
P6179
1003797789